Chenchao Liu is Managing Director of SILREAL GmbH, a boutique consultancy specialized in healthcare strategy, policy, and market access between Europe and China. He holds a degree in Chemistry from the Technical University of Munich and is a certified Project Management Professional (PMP). With over 11 years of experience advising multinational corporations and government bodies, Chenchao has delivered complex projects at the intersection of healthcare innovation, policy, and commercialization.

He has served clients including AstraZeneca, Bayer, CordenPharma, and the German Federal Ministry of Health, supporting policy inclusion, digital transformation, and cross-border collaboration. Notable achievements include enabling the inclusion of COPD into China’s National Public Health Scheme, leading Sino-European health summits, and managing digital rollouts for healthcare providers with 5,000+ staff.

Chenchao brings deep expertise in navigating regulatory landscapes (e.g., MDR, FDA, NMPA) and crafting tailored go-to-market strategies for MedTech and pharma companies. He has published and spoken on topics including China’s digital health market, healthcare policy, and public-private partnerships at international platforms.

Chenchao is trilingual in German, English, and Chinese and maintains an extensive network among key stakeholders across healthcare industries and regulatory bodies. His work empowers organizations to expand access, foster innovation, and achieve operational excellence in complex regulatory environments.

At SILREAL, he is committed to bridging European and Asian healthcare innovation ecosystems to drive measurable impact for patients.

Dr. Khulood Alsayegh is a distinguished healthcare leader with over 20 years of clinical and regulatory expertise across Ireland, the USA, GCC, and UAE. Trained at the Royal College of Surgeons and Harvard Medical School, she is a multilingual international speaker who shapes transformative healthcare policies. As Head of Clinical Standards & Guidelines at Dubai Health Authority (DHA), she sets excellence benchmarks for Dubai’s public and private healthcare sectors.

A pioneer in AI ethics, Dr. Alsayegh is the Middle East and Africa’s first certified AI Lead Ethical Assessor in healthcare and serves on the UAE’s National Committee for AI Regulation. She integrates technology with precision medicine to redefine care delivery and frequently speaks at global conferences and universities.

Honored with the Emirati Women Award by H.E. Sheikh Ahmed bin Saeed Al Maktoum and recognized by the late H.E. Sheikh Hamdan Bin Rashid Al Maktoum, her work drives impactful change. She also advances healthcare governance as a Research Fellow at Mohamed bin Rashid School of Government.

Dr. Elena Startseva, is a pediatrician by training with over 20 years of global experience spanning clinical development, medical affairs, regulatory strategy, and portfolio leadership across multiple therapeutic areas. She has led cross-functional teams in both large pharmaceutical companies and biotech environments, driving innovation from early-stage development through late-phase evidence generation.

Currently serving as Senior Clinical Program Leader and Global Evidence Lead at Boehringer Ingelheim, Dr. Startseva oversees clinical strategy and data generation for late-phase programs in cardiovascular, renal, and metabolic diseases. Her previous leadership roles at Novo Nordisk, Sandoz, and InflaRx have included responsibilities in clinical due diligence, regulatory submissions, and medical strategy across immunology, oncology, and metabolic disorders.

Elena is passionate about advancing personalized medicine through data-driven innovation, including the use of digital twins, in silico trials, and external control arms. She brings a unique blend of scientific rigor, strategic insight, and entrepreneurial mindset, with a strong interest in translational medicine and venture creation. She is also an active mentor and contributor to scientific publications in the field of diabetes and obesity.

Marissa Emery is a healthcare strategist dedicated to expanding equitable access to essential diagnostics and care in low- and middle-income countries. With a background spanning laboratory medicine, point of care testing, and health systems strengthening, Marissa specializes in translating complex technical solutions into practical, scalable programs that make a tangible difference for underserved communities.Marissa has collaborated with ministries of health, NGOs, and local healthcare providers to design solutions that fit local contexts: from point-of-care diagnostics for maternal health to strengthening primary care networks. She believes strongly that innovative technology should benefit those who need it most, not just those who can afford it.Beyond her technical work, Marissa is an advocate for customer-centric approaches in MedTech and is passionate about developing teams that drive meaningful, people-focused change. With a proven ability to communicate complex topics clearly and align diverse partners, she brings a pragmatic yet ambitious perspective to the global health landscape.Outside of work, Marissa enjoys hiking in the Swiss Alps with her dog Alta, learning new languages, dancing, and sharing good wine with even better friends- because healthy communities start with healthy, thriving people.

Dr. Motaip Alrawili is a pediatric surgeon from Saudi Arabia with fellowship training in the United Kingdom. He later completed an Executive Fellowship in Surgical Leadership at King’s Health Partners in London. His work focuses on innovation in pediatric surgery, digital health, and improving access to specialized care for children.

Dr. Gerd Möller is Vice President of Medical Affairs in Europe at Syneos Health, where he leads the Field Medical Centre of Excellence. With over 20 years in Medical Affairs and a background in medicine, orthopedic surgery, and health economics, he brings deep clinical and strategic expertise. As a mentor and former paratrooper, Gerd is known for building high-performing teams and advancing medical excellence across Europe. He is also a published researcher and active voice in industry leadership and coaching.I look forward to contributing valuable insights to your audience of investors, startups, and industry leaders on how strategic Medical Affairs can accelerate pediatric MedTech innovation while ensuring patient safety and regulatory compliance.

Reinout Bem is a pediatrician performing clinical work and research at the pediatric Intensive care

Unit (PICU) of the Emma Children’s Hospital at Amsterdam University Medical Centers in Amsterdam, the Netherlands. He has almost 20 years of research experience in the field of acute lung diseases and respiratory support, with former PhD training in the Netherlands and United States of America. Topics of special interest include pediatric respiratory infectious diseases, invasive and non-invasive mechanical ventilation, oxygen therapy and respiratory mucus and aerosol dynamics. He has published over 75 articles in international peer-reviewed scientific journals and serves on the editorial board of Pediatric Critical Care Medicine. Most recently his research activities are focused on finding innovative solutions for personalizing non-invasive ventilation mask fit by using 3D techniques in children.

Bio (Dr. Loai Elsaadany is a British Pediatric Consultant with a Fellowship in the Royal College of Paediatrics and Child Health and a CCT in General Paediatrics with a subspecialty in Nephrology.

He has extensive experience across the UK and Qatar, holding consultant roles in tertiary centers such as Hamad Medical Corporation and Queens Medical Centre, Nottingham.

His clinical expertise spans acute pediatrics, nephrology, neurology, and neonatal care.

In addition to his clinical practice, Dr. Elsaadany is an active educator, mentoring medical students, residents, and fellows in both clinical and academic environments.

He has published peer-reviewed research and presented at leading pediatric and subspecialty conferences, including the RCPCH and the British Paediatric Neurology Association.

His academic work includes quality improvement initiatives, guideline development, and pioneering diagnostic approaches in pediatric care.

Dr. Elsaadany is passionate about integrating technology into healthcare to enhance diagnostic accuracy and patient outcomes.

He is currently leading two innovation projects applying artificial intelligence in pediatrics: an AI-assisted urinary tract infection (UTI) diagnostic pathway and an AI-driven structured pediatric history-taking tool.

These projects aim to reduce diagnostic delays, optimize antibiotic stewardship, and support clinicians in high-pressure environments.

In his practice, he champions faster, smarter, and less invasive approaches to diagnosis, improving patient comfort and family experience.

Dr. Elsaadany’s leadership roles have included developing hospital guidelines, coordinating pediatric services, and leading multicultural healthcare teams.

He has contributed to pediatric sepsis protocols, neonatal airway safety projects, and renal service improvements.

His vision is to bridge clinical expertise, cutting-edge diagnostics, and artificial intelligence to shape the future of pediatric medicine.

Dr. Vasiliki Vlacha is a pediatric hematologist-oncologist and the founder of AimaLabs, where she leads the development of an innovative AI-based platform that transforms peripheral blood smear analysis. Her work focuses on automating blood cell identification to address the underutilization of smear testing, aiming to reduce the 1.5 billion cases of delayed or misdiagnosed conditions such as anemia and leukemia worldwide. By eliminating manual bottlenecks in microscopy, AimaLabs helps reduce laboratory workloads and combat professional burnout.

She brings over 20 years of clinical and leadership experience, including roles as Consultant Pediatric Hematologist-Oncologist at Karamandaneio Children’s Hospital of Patras, Scientific Director at Olympion Private Hospital, and Head of the Pediatric Hematology Department at the University Hospital of Patras. Her international experience includes work at Good Samaritan Medical Center and Signature Healthcare in Massachusetts, U.S.A.

Dr. Nada Mallick MD, MBA, is a board-certified pediatric critical care physician with expertise in the care of critically ill children. She serves as the Medical Director of Respiratory Care, where she oversees clinical operations and innovation in respiratory therapy services. Her academic and clinical interests include quality improvement research, pediatric resuscitation, and the development of data-driven approaches to enhance patient outcomes. Dr. Mallick has led several multidisciplinary initiatives aimed at improving the timeliness of recognition and escalation of care for deteriorating patients. She has published and presented on topics related to critical care quality metrics, medical resuscitation, and systems-based approaches to safety and performance improvement. With dual training in medicine and business, Dr. Mallick brings a unique perspective to clinical leadership, blending operational efficiency with a focus on advancing patient-centered care.

With diverse medical experience spanning more than 20 specialties and sub-specialties, I bring a uniquely comprehensive understanding of healthcare delivery. My career has included roles in plastic and reconstructive surgery, trauma and orthopaedic surgery, emergency medicine, psychiatry, oncology, paediatrics, obstetrics and gynaecology, and general practice, reflecting adaptability and a commitment to patient-centered care.I am a Member of the Royal College of Surgeons (MRCS) and hold a Master’s Degree in Surgery from the Royal College of Surgeons in Ireland (RCSI). I also completed a Master’s degree in Psychology with a focus on social media and positive psychology. Recognized for academic excellence early in my career, I was awarded a scholarship to study medicine at RCSI. This interdisciplinary expertise underscores my dedication to fostering effective communication, innovation, and meaningful connections in healthcare.

As an MD, Master of Pharmaceutical Science, and Specialist in Clinical Biochemistry, I have over 25 years of combined experience in clinical medicine, academia, and clinical research in biochemistry, pharmacology, and immunological diseases. For 15 years, I served as Head of the Diagnostic Lab at the University Research Institute in Belgrade, Serbia. My expertise as a laboratory, clinical, and regulatory professional integrates scientific knowledge, regulatory compliance, risk assessment, data analysis, and project management, with a particular focus on immunological responses to medical devices and drugs. I have contributed as an expert on medical projects for the EU Commission and gained valuable international experience in London (UK), Fukuoka (Japan), Ras Al Khaimah (UAE), Belgrade (Serbia), and Rome (Italy).

Matheus (Roland) van Rens is a Dutch neonatal nurse practitioner, researcher, and international speaker with over 30 years of clinical experience in Europe and the Middle East. He has held senior leadership roles, including Director of Nursing at a large tertiary NICU in Qatar, and has extensive expertise in vascular access for newborns. Roland holds a Master’s in Advanced Nursing Practice from Erasmus University and is currently pursuing a PhD at Radboud University Medical Center on neonatal vascular access safety and innovation. His research addresses key challenges in infusion therapy, including infiltration and extravasation injuries, flow-rate variability, and catheter securement. He has been the principal investigator or co-investigator in several multicenter neonatal vascular access studies, and has authored peer-reviewed publications, consensus guidelines, and a book on neonatal vascular access and neurodevelopmental care, published by Springer. Roland collaborates with international networks such as NEVAT (Neonatal European Vascular Access Team) and the European Society for Paediatric Research (ESPR) Special Interest Group on Vascular Access.